Title: Supreme Court to Debate Restrictions on Widely Used Abortion Drug: A Round-up of the U.S Abortion Landscape
The Supreme Court is slated to contemplate restrictions over Mifepristone, a frequently used abortion medication. This drug, taken in conjunction with another medication, is quite prevalent in the U.S and has been on the market for over two decades during which it has been used by millions of women.
These discussions occur at a pivotal time as, despite the lower court rulings being placed on hold, the drug is currently accessible nationwide. Concerns are escalating given that over half of the abortions in the U.S are medicinal, and such drugs have been lawful for many years.
The previous year witnessed a landmark moment as the Supreme Court, viewed as conservative-leaning, overturned Roe v. Wade, causing a significant shift in the U.S abortion rights landscape. Now, with more than half the states either outlawing or severely limiting abortion procedures, the court's decision to review the case on Mifepristone will plunge it once more into the abortion debate. With a decision anticipated by July, the justices could find themselves engaged in the presidential election's discourse.
Meanwhile, abortion battles are also simmering at the state level. This week, the Texas Supreme Court ruled against a woman demanding the right to an abortion after she had left the state to obtain the procedure.
In another development, the Arizona Supreme Court is currently considering arguments from individuals opposing abortion who aspire to return to an 1864 state law that bans nearly all abortions. Should such a decision prevail, it could significantly impact the pregnant individuals of Arizona's ability to access this form of healthcare.
Lastly, in yet another debate on abortion restrictions, state Supreme Courts in Wyoming and New Mexico are hearing arguments this week. Meanwhile, in a contrasting move, Michigan's Governor Gretchen Whitmer signed a bill expanding access and repealing a state insurance coverage requirement.